Skip to main content
. 2017 Jul 21;8(35):59609–59617. doi: 10.18632/oncotarget.19425

Figure 2. The pooled HR of non-responders vs. responders for 1-year OS.

Figure 2

The summary estimates were obtained by using a random-effects model. The data markers indicate the HRs comparing non-responders with responders among cervical cancer patients undergoing neoadjuvant chemotherapy. The size of the data markers indicates the weight of the study, which is the inverse variance of the effect estimate. The diamond data markers indicate the pooled HRs.